PreprintAll rights reservedbioRxiv
5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI
- 1Indiana University School of Medicine
Related
- Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation
- Glaucoma neurodegeneration: targeted modulation of intraocular immune pathways – a review of novel therapeutic advances
- Angiopoietin-like protein 7 (ANGPTL7)-mediated effects on resident immune cells contribute to neurodegeneration in glaucomatous optic nerve head
- Arabidopsis NLR Immune Receptors: Structural Diversification, Signaling Networks, and Emerging Principles of Immune Activation
- Complement activation in immune thrombotic thrombocytopenic purpura: Possible amplifier and potential therapeutic opportunity.
BibTeX
@misc{das20265ht1a,
title = {{5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI}},
author = {A. Das and S. Dutta and L. K. Pradhan and J. Chen and N. Wang and X. Gao},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.11.758371},
url = {https://www.biorxiv.org/content/10.64898/2026.10.11.758371v1},
}
RIS
TY - UNPB
TI - 5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI
AU - A. Das
AU - S. Dutta
AU - L. K. Pradhan
AU - J. Chen
AU - N. Wang
AU - X. Gao
PY - 2026
DA - 2026/10/11
PB - bioRxiv
DO - 10.64898/2026.10.11.758371
UR - https://www.biorxiv.org/content/10.64898/2026.10.11.758371v1
ER -